The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for C Yi


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
22
Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors.EBI
Pkucare Pharmaceutical R & D Center
22
Synthesis and structure-activity relationships of PI3K/mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3-d]pyrimidine derivatives.EBI
Pkucare Pharmaceutical R & D Center
31
Identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors.EBI
Pkucare Pharmaceutical R & D Center
4
Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases.EBI
Peking University
10
Recent advances in gout drugs.EBI
Peking University
16
Design, synthesis and evaluation of novel monoamine oxidase B (MAO-B) inhibitors with improved pharmacokinetic properties for Parkinson's disease.EBI
Hec Pharm Group
10
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter.EBI
Central China Normal University
17
Novel difluoromethyl-containing 1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1H-indole scaffold as potent 5-HTEBI
Hec Pharm Group
20
Novel difluoromethylated 1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole derivatives as potent 5-HTEBI
Hec Research and Development Center
16
Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.EBI
Central China Normal University
39
8-Hydroxyquinolin-2(1H)-one analogues as potential βEBI
Shenyang Pharmaceutical University
12
Design, synthesis and biological evaluation of pyridinylmethylenepiperidine derivatives as potent 5-HTEBI
Sunshine Lake Pharma
53
From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis.EBI
East China Normal University
35
Design, synthesis and biological evaluation of 8-(2-amino-1-hydroxyethyl)-6-hydroxy-1,4-benzoxazine-3(4H)-one derivatives as potent βEBI
Shenyang Pharmaceutical University
26
Design, synthesis and biological evaluation of 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one derivatives as potent βEBI
Shenyang Pharmaceutical University
3
Carbonic anhydrase I and II inhibition with natural products: caffeine and piperine.BDB
Gitam University
24
Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.BDB
Bryn Mawr College